Financial DD of Vitaprotech in the context of the sale of Eurazeo’s stake
20 Jul 2022
20 Jul 2022
Eight Advisory performed the financial due diligence of the Vitaprotech group in the context of the sale of Eurazeo's stake to Apax Partners.
Founded in 2012, Vitaprotech addresses all of its clients’ needs in terms of securing sensitive sites, through an integrated offering built around three complementary areas of expertise: access control, perimeter intrusion detection, intelligent monitoring & video. Ambitious to reach a turnover of more than €80M by 2022, Vitaprotech has tripled in size since 2018 and now has more than 400 employees in France, Germany, the UK and the US.
Eurazeo is an investment company with €32bn in assets under management (AuM) and 530 portfolio companies as of March 31, 2022. Eurazeo serves clients worldwide through its 12 offices around the world.
Eurazeo has supported Vitaprotech since 2018 and today announces the signing of an exclusivity agreement with Apax Partners for the sale of its stake in Vitaprotech. The transaction would remain subject to applicable regulatory approvals.
The Eight Advisory team in charge of the financial due diligence was composed of Christian Berling, Maxime Goerens and Antoine Chaucesse.